Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Share-based Compensation: 2018-2019

Historic Share-based Compensation for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $401,000.

  • DiaMedica Therapeutics' Share-based Compensation rose 516.92% to $401,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.2 million, marking a year-over-year increase of 87.74%. This contributed to the annual value of $2.1 million for FY2024, which is 23.89% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Share-based Compensation of $401,000 as of Q4 2019, which was down 11.09% from $451,000 recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Share-based Compensation peaked at $451,000 during Q3 2019, and registered a low of $65,000 during Q4 2018.
  • For the 2-year period, DiaMedica Therapeutics' Share-based Compensation averaged around $223,000, with its median value being $167,500 (2018).
  • Examining YoY changes over the last 5 years, DiaMedica Therapeutics' Share-based Compensation showed a top increase of 516.92% in 2019 and a maximum decrease of 37.67% in 2019.
  • Over the past 2 years, DiaMedica Therapeutics' Share-based Compensation (Quarterly) stood at $65,000 in 2018, then skyrocketed by 516.92% to $401,000 in 2019.
  • Its last three reported values are $401,000 in Q4 2019, $451,000 for Q3 2019, and $182,000 during Q2 2019.